EUVIMEDEUVIMED entdecken
Crossref

Comparing adenosine A 2A receptor modulation of cannabinoid CB 1 receptor‐mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals

Samira G Ferreira, Rafael M Bitencourt, Pedro Garção, Rodrigo A Cunha iD, Attila Köfalvi iD

European Journal of Neuroscience · 2025

DOI: 10.1111/ejn.16642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2025. Verfasst von Samira G Ferreira und 4 weiteren Autor:innen. Beteiligte Einrichtung: CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Glutamic Acid, Corpus Striatum, gamma-Aminobutyric Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: European Regional Development Fund, FCT-Fundação para a Ciência e a Tecnologia, CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In corticostriatal nerve terminals, glutamate release is stimulated by adenosine via A 2A receptors (A 2A Rs) and simultaneously inhibited by endocannabinoids via CB 1 receptors (CB 1 Rs). We previously identified presynaptic A 2A R–CB 1 R heterotetrameric complexes in corticostriatal nerve terminals. We now explored the possible functional interaction between A 2A Rs and CB 1 Rs in purified striatal GABAergic nerve terminals (synaptosomes) and compared these findings with those on the release of glutamate. In the striatal synaptosomes of rats and wild‐type mice, the synthetic cannabinoid receptor agonist WIN55212‐2 (10–1000 nM) attenuated the Ca 2+ ‐dependent, high‐K + ‐evoked release of γ‐[2,3‐ 3 H(N)]‐aminobutyric acid ([ 3 H]GABA) and [ 3 H]glutamate. WIN55212‐2 did not affect the evoked release of either neurotransmitter under CB 1 R blockade by AM251 or O‐2050 or in CB 1 R knockout (KO) mice. The A 2A R‐selective agonist CGS21680 (30 nM) and the A 2A R‐selective antagonist SCH58261 (100 nM) dampened the inhibitory action of WIN55212‐2 in rat synaptosomes. Another A 2A R‐selective antagonist, ZM241385 (100 nM), abolished the inhibition by WIN55212‐2 of the evoked release of both [ 3 H]GABA and [ 3 H]glutamate. Surprisingly, WIN55212‐2 also failed to inhibit the evoked release of [ 3 H]GABA but not of [ 3 H]glutamate in A 2A R KO mice of both CD‐1 and C57BL/6 strains. In rat striatal synaptosomal membranes, the binding of [ 3 H]ZM241385 to A 2A Rs was not affected by cannabinoids. However, ZM241385 reduced the B max while CGS21680 and SCH58261 increased the K D of [ 3 H]SR141716A binding to CB 1 R, indicating an A 2A R‐ligand‐specific modulation of CB 1 R function. CB 1 R B max and K D were reduced in A 2A R KO mice, whereas A 2A R B max was smaller in CB 1 R KO mice. Altogether, our data reveal an intricate interdependence of presynaptic A 2A Rs and CB 1 Rs on striatal neuromodulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Glutamic AcidCorpus Striatumgamma-Aminobutyric AcidReceptor, Adenosine A2ASynaptosomesMice, KnockoutAnimalsMaleRatsMiceBenzoxazinesMice, Inbred C57BLMorpholinesNaphthalenesRats, WistarPresynaptic Terminals

Stichwörter der Autor:innen

A2A receptorCB1 receptorGABAGPCR heteromerizationglutamatestriatum

Substanzen

Receptor, Cannabinoid, CB1Glutamic Acidgamma-Aminobutyric AcidReceptor, Adenosine A2A(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneBenzoxazinesMorpholinesNaphthalenes

Autor:innen und Institutionen

  • CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Postgraduate Program in Health Sciences, University of South Santa Catarina, Tubarão, Brazil.
  • Talisman Therapeutics, Jonas Webb Building, Babraham Research Campus, Cambridge, UK.
  • Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

ORCID-Profile: Rodrigo A Cunha, Attila Köfalvi

Förderung

  • European Regional Development Fund
  • FCT-Fundação para a Ciência e a Tecnologia
  • CNPq
  • CAPS
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Center for AIDS Prevention Studies, University of California, San Francisco

Zitieren

APA

Ferreira, S. G., Bitencourt, R. M., Garção, P., Cunha, R. A., & Köfalvi, A. (2025). Comparing adenosine A 2A receptor modulation of cannabinoid CB 1 receptor‐mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16642

Vancouver

Ferreira SG, Bitencourt RM, Garção P, Cunha RA, Köfalvi A. Comparing adenosine A 2A receptor modulation of cannabinoid CB 1 receptor‐mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals. European Journal of Neuroscience. 2025. doi:10.1111/ejn.16642

BibTeX
@article{Ferreira2025,
  author = {Ferreira, Samira G and Bitencourt, Rafael M and Garção, Pedro and Cunha, Rodrigo A and Köfalvi, Attila},
  title = {Comparing adenosine A 2A receptor modulation of cannabinoid CB 1 receptor‐mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals},
  journal = {European Journal of Neuroscience},
  year = {2025},
  doi = {10.1111/ejn.16642}
}
Kostenlos starten →